Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
These medications are FDA-approved for chronic weight management in adults with a BMI of 30 or greater (obesity) or a BMI of 27 or greater (overweight) with at least one weight-related health condition such as hypertension, type 2 diabetes, or high cholesterol
September 26, 2023: Vaccine/Injection Tips, Oral phenylephrine, Cystitis MA Update Read Now Summary/Highlights Respiratory Virus Season Vaccine and injection tools you should be using this fall Drug Shortages Ozempic 1mg pen: shortage documents for diabetes and obesity Tamsulosin SR capsules Minor Ailments Cystitis update Professional Practice Oral phenylephrine: It'SNot effective New Information from Past Newsletters Domperidone safety review completed by Health Canada From the medSask Database Safety of combination treatment with tranexamic acid (TXA) and combined hormonal contraceptives (CHCs) for reducing menstrual blood loss Kaitlyn's Resource Share: Natural Medicines Database Share your feedback with medSask
[7] It should not be used in individuals with hormone-sensitive tumors, such as prostate cancer or breast cancer, due to the risk of stimulating tumor growth through increased androgen or estrogen production
A simple blood test can identify if a hormonal imbalance is the reason behind a missed or delayed period
BPC-157: An Emerging Hope for IC Treatment Exploring the impact of BPC-157 on interstitial cystitis reveals a potentially transformative avenue for treatment
